Arch Venture Management, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $166 Million distributed in 9 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Beam Therapeutics Inc. with a value of $118M, Erasca, Inc. with a value of $30.2M, Verve Therapeutics, Inc. with a value of $9.72M, Gossamer Bio, Inc. with a value of $7.98M, and Unity Biotechnology, Inc. with a value of $0.

Examining the 13F form we can see an decrease of $4.35M in the current position value, from $171M to 166M.

Arch Venture Management, LLC is based out at Chicago, IL

Below you can find more details about Arch Venture Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $166 Million
Healthcare: $166 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 9
  • Current Value $166 Million
  • Prior Value $171 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Arch Venture Management, LLC Portfolio

Follow Arch Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arch Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arch Venture Management, LLC with notifications on news.